Smoking isn’t the only risk factor: busting myths around lung cancer

Account subscription benefits alongside Premium Stories, Editorials, Opinions and more. Unlock these with Subscription

A lung cancer diagnosis has a way of stopping a conversation cold. Families go quiet. Plans get shelved. The assumption, almost universal, is that the outcome is already decided. Often, that assumption is wrong. When the disease is found early, meaningful treatment is possible , curative intent included. The gap between what people believe about lung cancer and what medicine can actually offer has never been wider.

Where does this belief come from? In India, most patients present in advanced stage, and because of this, the treatment options decrease exponentially. The outcomes families witness reinforce a fatalism that’s hard to shake. Late detection is the problem, not an inherent quality of the disease itself. Lung cancer found at an early, localised stage is genuinely treatable. Surgery with curative intent is possible. The question that matters most is how soon the disease gets diagnosed.

Smoking is the most well-known risk factor, and for good reason. But the picture is more complicated. Prolonged exposure to indoor cooking fuel smoke or second-hand smoke carries considerable risk, as does long-term exposure to occupational carcinogens. Registry data from India has shown a steady rise in cases among women and adults who have never smoked . Adenocarcinoma, now the most commonly diagnosed lung cancer subtype in India, occurs frequently in this group. It also tends to carry specific genetic mutations that respond well to targeted treatment. Any respiratory symptom that doesn’t resolve deserves attention, irrespective of smoking history.

This is the myth that probably causes the most harm. Lung cancer is often silent early on, and when symptoms surface, they look like something else entirely. A cough that has outstayed its welcome. Recurring chest infections. Unexplained weight loss, or breathlessness that keeps getting worse. Any of these, persisting beyond three weeks, should prompt clinical evaluation. Some features call for more urgency: coughing up blood, a voice that turns persistently hoarse, chest pain that doesn’t shift. Attributing such signs to the weather or getting older is understandable, but it is also how early lung cancer gets missed.

The stage at diagnosis is an important factor in how lung cancer plays out. Finding it early and getting it surgically removal with curative intent becomes a real possibility. This is where screening comes into the picture. Low-dose CT scanning picks up small nodules in the lung before a patient feels anything, creating a window for treatment that wouldn’t otherwise exist. Indian health economic research has confirmed this approach as cost-effective for those at highest risk. If you have a long smoking history and are above a certain age, it’s worth asking your doctor about screening.

The treatment landscape for lung cancer has shifted considerably. Molecular testing can now identify specific mutations within a tumour.